Document Actions
Documents and Special Reports
Reports and other documents of interest to readers.
- Sentencing hearing transcript of former Bristol-Myers Squibb executive Andrew Bodnar (referenced in The Cancer Letter, June 12, 2009).
- Stand Up to Cancer Q&A talking points (referenced in The Cancer Letter, May 29, 2009).
- Leslie Bernstein letter to Sen. Amy Klobuchar on the EARLY Act (quoted in TCL April 10, 2009).
- National Breast Cancer Coalition's analysis of the EARLY Act (mentioned in TCL April 10, 2009).
- NIH Acting Director Raynard Kington remarks Feb. 18, 2009, on plans for spending $10.4 billion economic stimulus funds, and question-and-answer session. (Two separate audio files).
- Letter from the Accreditation Council for Continuing Medical Education regarding sanctioning of the Massachusetts Medical Society on I-ELCAP study. Notice of Correction Action by MMS.
- Meeting materials from Early Analysis of Lung Screening Data meeting Sept. 22-23, 2008.
- Cell Phone studies in a table compiled by ACS staff.
- Ortho vs. Amgen: Complaint
- Ortho vs. Amgen: Defendant's Memorandum
- FDA Oncology Drug Approvals from 2005-2008 (PowerPoint presentation).
- Transcript of NCI Board of Scientific Advisors discussion of ESA and Tumor Growth RFA concept.
- NCI RFA Concept on ESAs and Tumor Growth as presented to BSA on June 23, 2008.
- Report from NCI workshop on ESAs and Tumor Growth, Dec. 2007.
- NIH response to Dingell-Stupak letter on alleged conflicts in NLST.
- Sen. Grassley letter on conflicts in NIH extramural program, June 4, 2008.
- FDA's Professional Needs Budget sent to Sen. Arlen Specter May 5, 2008.
- FDA documents on Procrit direct-to-consumer advertising compiled by the Subcommittee on Oversight and Investigations of the House Committee on Energy & Commerce for a May 8, 2008, hearing.
- NSABP Response to NIH Rejection of P-4 Appeal.
- NIH Rejection of NSABP Appeal on P-4 Trial Cancellation.
- NSABP memo of March 26, 2008, on changes to informed consent policies.
- Indictment of Andrew Bodnar, former Bristol-Myers Squibb executive.
- Claudia Henschke's disclosure letter to American Cancer Society, Feb. 7, 2008.
- The NCI 2015 Goal (Special Report, August 2003)
- The National Dialogue on Cancer 2000-2002 (Special Report, August 2003)
- ImClone: The C225 Controversy (Special Report, March 2002)
Forgot your password?